The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Cyclin E, a Potential Prognostic Marker in Breast Cancer.
Abstract
A fundamental cause of cancer is changed properties of genetic material, which may deregulate normal development of the tissue or provide selective growth advantage to the tumor cell. This deregulation of cell proliferation results from altered production of a handful of proteins that play key roles in progression through the eukaryotic cell cycle. Some of these proteins include tumor suppressor genes or oncogenes. However, no one general change or alteration of a critical gene has yet been found in all cancers. Using surgical material obtained from patients with various malignancies, we show that breast cancers and other solid tumors, as well as malignant lymphocytes from patients with lymphatic leukemia, show severe quantitative and qualitative alterations in cyclin E protein production independent of the S-phase fraction of the samples. Hence, these alterations represent a true difference between normal versus tumor tissue. In addition, in breast cancer, the alterations in cyclin E expression become progressively worse with increasing stage and grade of the tumor, suggesting its potential use as a new prognostic marker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., et al. (1981) · Cancer · doi:10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v · Cited by 1,778
Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ
Bravo, R., Frank, R., Blundell, P. A., & Macdonald-Bravo, H. (1987) · Nature · doi:10.1038/326515a0 · Cited by 1,740
A novel cyclin encoded by a bcl1-linked candidate oncogene
Motokura, T., Bloom, T., Kim, H. G., Jüppner., H., Ruderman, J. V., Kronenberg, H. M., & Arnold, A. (1991) · Nature · doi:10.1038/350512a0 · Cited by 1,265
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein
Prelich, G., Tan, C.-K., Kostura, M., Mathews, M. B., So, A. G., Downey, K. M., & Stillman, B. (1987) · Nature · doi:10.1038/326517a0 · Cited by 1,059
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Boring, C. C., Squires, T. S., & Tong, T. (1993) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.43.1.7 · Cited by 966
Association of human cyclin E with a periodic G1-S phase protein kinase
Dulic, V, Lees, E., & Reed, S. (1992) · Science · doi:10.1126/science.1329201 · Cited by 881
Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B
Pines, J., & Hunter, T. (1990) · Nature · doi:10.1038/346760a0 · Cited by 715
Hunter, T., & Pines, J. (1991) · Cell · doi:10.1016/0092-8674(91)90028-w · Cited by 688
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Redundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi, K., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1112 · Cited by 512
Self-citationA search for differential polypeptide synthesis throughout the cell cycle of HeLa cells.
Bravo, R., & Celis, J. E. (1980) · The Journal of cell biology · doi:10.1083/jcb.84.3.795 · Cited by 462
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees, E., Faha, B., Dulic, V, Reed, S. I., & Harlow, E. (1992) · Genes & Development · doi:10.1101/gad.6.10.1874 · Cited by 438
Amplification and expression of the human cyclin D gene in esophageal cancer.
Jiang, W. B., Kahn, S. M., Tomita, N., Zhang, Y. J., Lu, S., & Weinstein, I. B. (1992) · PubMed · Cited by 404
Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R. J. A. M., Dickson, C., Arnold, A., & Peters, G. B. (1991) · PubMed · Cited by 371
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai, L., Lees, E. M., Faha, B., Harlow, E. E., & Riabowol, K. T. (1993) · PubMed · Cited by 310
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
Giordano, A., Whyte, P., Harlow, E., Franza, B. R., Beach, D., & Draetta, G. (1989) · Cell · doi:10.1016/0092-8674(89)90949-5 · Cited by 252
DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., & Livingston, D. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1795 · Cited by 232
Interaction Between Human Cyclin A and Adenovirus E1A-Associated p107 Protein
Faha, B., Ewen, M. E., Tsai, L.-H., Livingston, D. M., & Harlow, E. (1992) · Science · doi:10.1126/science.1532458 · Cited by 210
Rosenberg, C. L., Kim, H. G., Shows, T. B., Kronenberg, H. M., & Arnold, A. (1991) · PubMed · Cited by 196
Amplification of cyclin genes in colorectal carcinomas.
Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1993) · PubMed · Cited by 192
Overexpression of cyclin D1 in mouse skin carcinogenesis.
Ab, B., Sm, F., Robles, A. I., et al. (1993) · PubMed · Cited by 117
Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer
Fantl, V., Richards, M. A., Smith, D., Lammie, G. A., Johnstone, G., Allen, D., Gregory, W. M., Peters, G., Dickson, C., & Barnes, D. M. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90009-i · Cited by 114
Fazely, F., Dezube, B. J., Allen-Ryan, J., Pardee, A., & Ruprecht, R. (1991) · Blood · doi:10.1182/blood.v77.8.1653.1653 · Cited by 109
BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet, C. G., Adnane, J., Szepetowski, P., Simon, M., Jeanteur, P., Birnbaum, D., & Gaudray, P. (1990) · PubMed · Cited by 76
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
Metadata
- Authors
- Keyomarsi, K.
- Publisher
- Defense Technical Information Center
- Published
- 1997-10-01
- Volume
- 54
- Issue
- 2
- Pages
- 380-5
- OpenAlex
- W2156157871
- Cited by
- 344
- References
- 30
- Type
- report
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.